Publications (18) Publications in which a researcher has participated

filter_list Hepatology

2024

  1. Deciphering the Role of Post-Translational Modifications and Cellular Location of Hepatitis Delta Virus (HDV) Antigens in HDV-Mediated Liver Damage in Mice

    Viruses, Vol. 16, Núm. 3

  2. Gene editing in liver diseases

    FEBS Letters, Vol. 598, Núm. 19, pp. 2348-2371

  3. Harnessing whole human liver ex situ normothermic perfusion for preclinical AAV vector evaluation

    Nature Communications, Vol. 15, Núm. 1

  4. In Vivo Selection of S/MAR Sequences to Favour AAV Episomal Maintenance in Dividing Cells

    International Journal of Molecular Sciences, Vol. 25, Núm. 23

  5. Protective role of RIPK1 scaffolding against HDV-induced hepatocyte cell death and the significance of cytokines in mice

    PLoS Pathogens, Vol. 20, Núm. 5

2023

  1. Assessment of Pre-Clinical Liver Models Based on Their Ability to Predict the Liver-Tropism of Adeno-Associated Virus Vectors

    Human gene therapy, Vol. 34, Núm. 7-8, pp. 273-288

  2. Exogenous aralar/slc25a12 can replace citrin/slc25a13 as malate aspartate shuttle component in liver

    Molecular Genetics and Metabolism Reports, Vol. 35

  3. Gene therapy for liver diseases — progress and challenges

    Nature Reviews Gastroenterology and Hepatology, Vol. 20, Núm. 5, pp. 288-305

  4. Topoisomerase Inhibitors Increase Episomal DNA Expression by Inducing the Integration of Episomal DNA in Hepatic Cells

    Pharmaceutics, Vol. 15, Núm. 10

2022

  1. Gene Therapy for Acquired and Genetic Cholestasis

    Biomedicines, Vol. 10, Núm. 6

  2. Inspecting the Ribozyme Region of Hepatitis Delta Virus Genotype 1: Conservation and Variability

    Viruses, Vol. 14, Núm. 2

  3. mRNA and gene editing: Late breaking therapies in liver diseases

    Hepatology, Vol. 76, Núm. 3, pp. 869-887

2021

  1. Linking the Expression of Therapeutic Genes to Unfolded Protein Response: A New Option for Anti-Hepatitis B Virus Gene Therapy

    Human Gene Therapy, Vol. 32, Núm. 7-8, pp. 341-348

2020

  1. Brain ventricular enlargement in human and murine acute intermittent porphyria

    Human molecular genetics, Vol. 29, Núm. 19, pp. 3211-3223

2019

  1. Gene therapy for progressive familial intrahepatic cholestasis type 3 in a clinically relevant mouse model

    Nature Communications, Vol. 10, Núm. 1

  2. Genetic-Based Approaches to Inherited Metabolic Liver Diseases

    Human Gene Therapy, Vol. 30, Núm. 10, pp. 1190-1203

  3. Liver Expression of a MiniATP7B Gene Results in Long-Term Restoration of Copper Homeostasis in a Wilson Disease Model in Mice

    Hepatology, Vol. 70, Núm. 1, pp. 108-126

2018

  1. Erratum to “A new HDV mouse model identifies mitochondrial antiviral signaling protein (MAVS) as a key player in IFN-β induction” [J Hepatol 67 (2017) 669–679] (S0168827817320469) (10.1016/j.jhep.2017.05.010))

    Journal of Hepatology